About this video
- Video Title: Sarcomas Uterinos [2025]
- Channel: Ginecología Oncológica INCan-México
- Speakers: Dra. Génesis Garcia
- Duration: 00:43:01
Overview
This video provides a comprehensive overview of uterine sarcomas, covering their general characteristics, epidemiology, risk factors, various histological subtypes, diagnostic approaches, staging, surgical management, adjuvant therapies, and follow-up strategies. The presentation aims to educate on the complexities of these rare but aggressive gynecological tumors.
Key takeaways
- Uterine sarcomas are a heterogeneous group of mesenchymal tumors, comprising less than 1% of gynecological malignancies, characterized by rapid growth and an often unclear origin from the mesoderm.
- Key subtypes include leiomyosarcoma (the most prevalent), endometrial stromal sarcoma (low and high grade), and adenosarcoma, each with distinct histological features and prognoses.
- While clear risk factors are elusive, tamoxifen use, pelvic radiation, obesity, and certain genetic syndromes like Lynch are associated with increased risk. Genetic mutations in p53 and retinoblastoma genes are also noted.
- Diagnosis can be challenging, as patients often present post-surgery for presumed benign conditions. Imaging (ultrasound, MRI, CT, PET-CT) and biopsy are crucial, though biopsy has a significant false-negative rate.
- Standard treatment centers on surgical management, typically a total hysterectomy with bilateral salpingo-oophorectomy. The approach aims for complete tumor removal with negative margins, and morcellation is contraindicated.
- Adjuvant therapies like chemotherapy and radiotherapy are considered, especially in advanced stages or for specific subtypes, though their role in early-stage disease is still debated. Hormonal therapy may be an option for tumors expressing hormone receptors.
- Follow-up is critical due to high recurrence rates, with regular imaging (CT scans of chest, abdomen, and pelvis) being essential, particularly for monitoring lung metastases, which are common. Prognostic factors include tumor stage, grade, size, and surgical margins.
